“Strong” position has led to investments

Despite facing PBS reform and intense competition, API reports $25 million net profit after tax and $2 billion in revenue in its half-year results for 2019 Australian Pharmaceutical Industries (API) has this week reported its half-year results, with total revenue for the six months up 6.6% to $1.98 billion after adjusting out the impact of